Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers

Adalimumab (ADA) was approved in Italy for the treatment of ulcerative colitis (UC) unresponsive to standard treatments in 2014, but no data from real life are currently available. The aim of the present study was to assess the real-life efficacy and safety of ADA in managing UC outpatients in some...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Medicine (Baltimore)
Główni autorzy: Tursi, Antonio, Elisei, Walter, Faggiani, Roberto, Allegretta, Leonardo, Valle, Nicola Della, Forti, Giacomo, Franceschi, Marilisa, Ferronato, Antonio, Gallina, Sara, Larussa, Tiziana, Luzza, Francesco, Lorenzetti, Roberto, Mocci, Giammarco, Penna, Antonio, Rodino’, Stefano, Sebkova, Ladislava, de Medici, Antonio, Pranzo, Giuseppe, Ricciardelli, Cristina, Grasso, Giuseppina, Scorza, Stefano, Zampaletta, Costantino, Picchio, Marcello
Format: Artigo
Język:Inglês
Wydane: Wolters Kluwer Health 2018
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6112877/
https://ncbi.nlm.nih.gov/pubmed/30142791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011897
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy